Zentek (ZTEK) Net Income towards Common Stockholders (2020 - 2025)
Zentek's (ZTEK) quarterly Net Income towards Common Stockholders came in at -$42919.0 in Q4 2025, down 102.32% year-on-year from $1.8 million in Q4 2024, and up 44.08% quarter-over-quarter from -$76748.6 in Q3 2025.
Zentek (ZTEK) Net Income towards Common Stockholders (2020 - 2025) Analysis & Trends
Zentek has disclosed Net Income towards Common Stockholders across 6 years of filings, most recently posting -$42919.0 for Q4 2025.
- Net Income towards Common Stockholders for Q4 2025 came in at -$42919.0, down 102.32% year-over-year; the trailing twelve-month figure through Dec 2025 was -$888813.8 (down 168.75% YoY), and the FY2025 annual result was -$6.9 million, up 23.12% from the prior year.
- Net Income towards Common Stockholders came in at -$42919.0 for Q4 2025 at Zentek, up from -$76748.6 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $21.2 million in Q3 2021 to a low of -$6.3 million in Q1 2021.
- The 5-year median for Net Income towards Common Stockholders is -$59833.8 (2025), against an average of $1.5 million.
- Peak annual rise in Net Income towards Common Stockholders reached 75.41% in 2025, while the deepest fall reached 102.32% in 2025.
- Zentek's Net Income towards Common Stockholders stood at $21.2 million in 2021, then sank by 82.36% to $3.7 million in 2022, then tumbled by 31.36% to $2.6 million in 2023, then declined by 27.95% to $1.8 million in 2024, then slumped by 102.32% to -$42919.0 in 2025.
- The last three Net Income towards Common Stockholders figures came in at -$42919.0 (Q4 2025), -$76748.6 (Q3 2025), and -$1.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.00 Mn |
| 10 | Zentek | - | - | -17,861.19 | -42,919.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -42,919.05 |
| Sep 30, 2025 | -76,748.64 |
| Jun 30, 2025 | -1.28 Mn |
| Mar 31, 2025 | 514,874.23 |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | -312,054.97 |
| Jun 30, 2024 | -1.87 Mn |
| Dec 31, 2023 | 2.57 Mn |
| Jun 30, 2023 | -2.39 Mn |
| Dec 31, 2022 | 3.74 Mn |
| Sep 30, 2021 | 21.19 Mn |
| Mar 31, 2021 | -6.34 Mn |
| Dec 31, 2020 | 1.88 Mn |